{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:21:27Z","timestamp":1790601687708,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Polycystic Ovary Syndrome (PCOS) affects 5-20% of reproductive-aged women. Insulin resistance (IR) is common in PCOS with consequent elevated risks of metabolic disorders and cardiovascular mortality. PCOS and obesity are complex conditions associated with Metabolic Syndrome (MS), contributing to cardiovascular disease and type 2 diabetes mellitus (T2D). Obesity and PCOS exacerbate each other, with central obesity driving metabolic changes. Mitochondrial dysfunction, characterized by oxidative stress and reduced antioxidant capacity, plays a key role in PCOS pathology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In our study, we investigated 81 women with PCOS, and 57 control women aged 16 to 46 years old. Relative mitochondrial DNA (mtDNA) content and its oxidation level (8-oxoguanine, 8-OxoG) were determined in peripheral blood leukocytes by the SYBR Green method real-time PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings showed that patients with PCOS had decreased mtDNA content and increased oxidation damage. Stratifying these patients by metabolic profile, revealed a progressive decline in mtDNA content from the normal-weight control group to the MHO-PCOS and MUO-PCOS groups, suggesting that lower mtDNA content is linked to obesity and worse metabolic profile. However, mtDNA oxidation levels did not differ significantly among these groups. Additionally, the decline in mtDNA content and the increase in oxidation levels between controls and patients with PCOS lost significance when these relationships were adjusted for the HOMA index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This finding suggests that IR could be the main factor contributing to mitochondrial dysfunction in PCOS. Maintaining optimal mtDNA copies are crucial for mitochondrial and cell function, suggesting potential therapeutic targets for PCOS-associated metabolic disturbances.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1501306","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:11:09Z","timestamp":1736399469000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Mitochondrial DNA oxidation and content in different metabolic phenotypes of women with polycystic ovary syndrome"],"prefix":"10.3389","volume":"15","author":[{"given":"Mail\u00e9n","family":"Rojo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Liliana","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Constanza","family":"Pautasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Adriana","family":"Abruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Beatriz","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Daniel","family":"Frechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Edith","family":"Cerrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American association of clinical endocrinologists, American college of endocrinology, and androgen excess and pcos society disease state clinical review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - Part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22083923","article-title":"Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome","volume":"22","author":"Dabravolski","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/clep.s37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"19","author":"Tarlatzis","year":"2004","journal-title":"Hum Reprod"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70286-3","article-title":"Polycystic ovary syndrome","volume":"26","author":"D.","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/ijem.ijem_637_18","article-title":"Obese and non-obese polycystic ovarian syndrome: Comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene","volume":"23","author":"Sachdeva","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"440\u201350","DOI":"10.1002\/em","article-title":"Mitochondrial DNAMutations in disease and aging","volume":"51","author":"Wallace","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijpvm.IJPVM","article-title":"Oxidative stress and polycystic ovary syndrome: A brief review abstract","volume":"10","author":"Mohammadi","year":"2019","journal-title":"Int J Prev Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12958-023-01159-6","article-title":"The potential diagnostic use of clinical characteristics and mitochondrial DNA copy numbers of peripheral blood and ovarian tissue in polycystic ovary syndrome (PCOS) patient","volume":"21","author":"Song","year":"2023","journal-title":"Reprod Biol Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.604215","article-title":"Telomere length differently associated to obesity and hyperandrogenism in women with polycystic ovary syndrome","volume":"12","author":"Velazquez","year":"2021","journal-title":"Front Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0165","article-title":"Metabolic and body composition factors in subgroups of obesity: What do we know","volume":"89","author":"Karelis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2005.130","article-title":"Prevalence of uncomplicated obesity in an Italian obese population","volume":"13","author":"Iacobellis","year":"2005","journal-title":"Obes Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Intern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.035","article-title":"Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Tr\u00f8ndelag Health Study), Norway","volume":"63","author":"M\u00f8rkedal","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.004.Distinguishing","article-title":"Distinguishing characteristics of metabolically healthy versus metabolically unhealthy obese adolescent girls with polycystic ovary syndrome","volume":"176","author":"Kim","year":"2017","journal-title":"Physiol Behav"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.12.029","article-title":"Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome","volume":"107","author":"Liang","year":"2017","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12824","article-title":"Prevalence of polycystic ovary syndrome in a metabolically healthy obese population","volume":"146","author":"Mu","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113925","article-title":"Metabolically healthy obesity (Mho) vs. metabolically unhealthy obesity (muo) phenotypes in pcos: Association with endocrine-metabolic profile, adherence to the mediterranean diet, and body composition","volume":"13","author":"Barrea","year":"2021","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/3008093","article-title":"Relationship of mitochondrial DNA oxidation and content with metabolic syndrome and cardiovascular risk in obesity phenotypes","volume":"2024","author":"Rojo","year":"2024","journal-title":"J Obes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.18553\/jmcp.2003.9.s1.2","article-title":"The national cholesterol education program adult treatment panel III guidelines","volume":"9","author":"Lipsy","year":"2003","journal-title":"J Manag Care Pharm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2019.03.005","article-title":"Placental mitochondrial DNA copy number is associated with reduced birth weight in women with placental malaria","volume":"80","author":"Oktavianthi","year":"2019","journal-title":"Placenta"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg1907s68","article-title":"Real-time quantitative PCR analysis of mitochondrial DNA content","volume":"68","author":"Venegas","year":"2011","journal-title":"Curr Protoc Hum Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801473","article-title":"Thinking outside the nucleus: mitochondrial DNA copy number in health and disease","volume":"176","author":"Castellani","year":"2018","journal-title":"Physiol Behav"},{"key":"B24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mito.2020.02.006","article-title":"Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome","volume":"52","author":"Shukla","year":"2020","journal-title":"Mitochondrion"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/JME-21-0177","article-title":"The mitochondrial profile in women with polycystic ovary syndrome: impact of exercise","volume":"68","author":"Malamouli","year":"2022","journal-title":"J Mol Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2005.09.011","article-title":"High-resolution respirometry-a modern tool in aging research","volume":"41","author":"H\u00fctter","year":"2006","journal-title":"Exp Gerontol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0378-1119(97)00628-8","article-title":"Quantitation of age-related mitochondrial DNA deletions in rat tissues shows that their pattern of accumulation differs from that of humans","volume":"209","author":"Yowe","year":"1998","journal-title":"Gene"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2011.04.010","article-title":"Mitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome","volume":"60","author":"Lee","year":"2011","journal-title":"Metabolism"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340416","article-title":"Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain","volume":"34","author":"Mecocci","year":"1993","journal-title":"Ann Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.914338","article-title":"A case-control study on the oxidative status in women with polycystic ovary syndrome treated with clomiphene citrate","volume":"25","author":"Yildirim","year":"2019","journal-title":"Med Sci Monit"},{"key":"B31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-319-18741-9_5","article-title":"Molecular mechanisms of insulin resistance: an update","author":"Guti\u00e9rrez-Rodelo","year":"2017","journal-title":"Princ Diabetes Mellit Third Ed"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1501306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:11:12Z","timestamp":1736399472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1501306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":31,"alternative-id":["10.3389\/fendo.2024.1501306"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1501306","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"article-number":"1501306"}}